These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation. Johanson JF; Drossman DA; Panas R; Wahle A; Ueno R Aliment Pharmacol Ther; 2008 Apr; 27(8):685-96. PubMed ID: 18248656 [TBL] [Abstract][Full Text] [Related]
13. Safety evaluation of lubiprostone in the treatment of constipation and irritable bowel syndrome. Chamberlain SM; Rao SS Expert Opin Drug Saf; 2012 Sep; 11(5):841-50. PubMed ID: 22834474 [TBL] [Abstract][Full Text] [Related]
15. Lubiprostone for chronic constipation in adults. Drug Ther Bull; 2014 Apr; 52(4):42-4. PubMed ID: 24722574 [TBL] [Abstract][Full Text] [Related]
16. Lubiprostone: a new drug for the treatment of chronic idiopathic constipation. Baker DE Rev Gastroenterol Disord; 2007; 7(4):214-22. PubMed ID: 18192957 [TBL] [Abstract][Full Text] [Related]
17. Lubiprostone for the treatment of opioid-induced bowel dysfunction. Wong BS; Camilleri M Expert Opin Pharmacother; 2011 Apr; 12(6):983-90. PubMed ID: 21385112 [TBL] [Abstract][Full Text] [Related]
18. Lubiprostone, a locally acting chloride channel activator, in adult patients with chronic constipation: a double-blind, placebo-controlled, dose-ranging study to evaluate efficacy and safety. Johanson JF; Ueno R Aliment Pharmacol Ther; 2007 Jun; 25(11):1351-61. PubMed ID: 17509103 [TBL] [Abstract][Full Text] [Related]